The PD-L1 Atezolizumab Biosimilar Monoclonal Antibody (HDBS0009) is a cutting-edge biologic designed for research in the field of immuno-oncology. This antibody, derived from rabbit cells, specifically targets the PD-L1 protein, a key immune checkpoint molecule that suppresses the body's immune response to cancer cells. The PD-L1 Atezolizumab Biosimilar Monoclonal Antibody is highly reactive with human samples, making it a valuable tool for studying the expression and function of PD-L1 in cancer cells. It is validated for use in a variety of applications, including immunohistochemistry and flow cytometry, providing researchers with versatile options for analyzing PD-L1 expression levels in different contexts.
The PD-L1 protein plays a crucial role in immune evasion by cancer cells, allowing tumors to escape detection and destruction by the immune system. By targeting PD-L1 with antibodies like Atezolizumab, researchers can potentially restore the body's natural anti-tumor immune response, leading to improved outcomes for cancer patients.Overall, the Anti-PD-L1 Atezolizumab Biosimilar Monoclonal Antibody holds great promise for advancing our understanding of cancer immunotherapy and developing more effective treatments for patients facing a variety of cancer types.
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
MPDL3280A,RG7446
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA, Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
